Positive and Negative Associations of Human Leukocyte Antigen Variants with the Onset and Prognosis of Adult Glioblastoma Multiforme

Associations of genetic factors with malignant gliomas have been modest. We examined the relationships of human leukocyte antigen (HLA) and related polymorphisms to glioblastoma multiforme in adult Caucasians (non–Hispanic Whites) from the San Francisco Bay area. For 155 glioblastoma multiforme patients and 157 control subjects closely matched by ethnicity, age, and gender, PCR-based techniques resolved alleles at HLA-A, -B, -C, and -DRB1 loci along with short tandem repeat polymorphisms of MICA exon 5 and TNFb. By multivariable logistic regression, B*13 and the B*07-Cw*07 haplotype were positively associated with glioblastoma multiforme (P = 0.01 and <0.001, respectively), whereas Cw*01 was the only variant showing a negative association (P = 0.05). Among glioblastoma multiforme patients, progression to death after diagnosis was slower in those with A*32 (relative hazard, 0.45; P < 0.01) and faster in those with B*55 (relative hazard, 2.27; P < 0.01). Thus, both the occurrence and the prognosis of glioblastoma multiforme could be associated with specific but different HLA genotypes. B*07 and the B*07-Cw*07 haplotype are much more common in Caucasians than other ethnic groups in the U.S., which may partially explain the higher incidence of glioblastoma multiforme in Caucasians.

[1]  M. Torres,et al.  Nomenclature for factors of the HLA system. , 2011, Bulletin of the World Health Organization.

[2]  Sue Povey,et al.  Gene map of the extended human MHC , 2004, Nature Reviews Genetics.

[3]  C. Cobbs,et al.  Molecular typing of human leukocyte antigen and related polymorphisms following whole genome amplification. , 2004, Tissue antigens.

[4]  K. Hess,et al.  Glutathione S-Transferase Polymorphisms and Survival in Primary Malignant Glioma , 2004, Clinical Cancer Research.

[5]  K. Aldape,et al.  Glutathione-S-transferase variants and adult glioma. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[6]  R. Weil,et al.  A Functional Polymorphism in the EGF Gene Is Found with Increased Frequency in Glioblastoma Multiforme Patients and Is Associated with More Aggressive Disease , 2004, Cancer Research.

[7]  Y. Taketani,et al.  Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer , 2003, International journal of cancer.

[8]  W. Klitz,et al.  New HLA haplotype frequency reference standards: high-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans. , 2003, Tissue antigens.

[9]  A. Ahlbom,et al.  Cohort studies of association between self‐reported allergic conditions, immune‐related diagnoses and glioma and meningioma risk , 2003, International journal of cancer.

[10]  H. Grönberg,et al.  Familial brain tumours—genetics or environment? A nationwide cohort study of cancer risk in spouses and first‐degree relatives of brain tumour patients , 2003, International journal of cancer.

[11]  J. Hansen,et al.  Inheritable variable sizes of DNA stretches in the human MHC: conserved extended haplotypes and their fragments or blocks. , 2003, Tissue antigens.

[12]  Geetha Krishnan,et al.  Occupation and Adult Gliomas in the San Francisco Bay Area , 2003, Journal of occupational and environmental medicine.

[13]  M. Tommasino,et al.  Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women. , 2003, Human immunology.

[14]  Margaret Wrensch,et al.  Molecular epidemiology of glioblastoma. , 2003, Cancer journal.

[15]  W. Klitz,et al.  Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan. , 2002, Journal of the National Cancer Institute.

[16]  Effie W Petersdorf,et al.  Nomenclature for factors of the HLA system, 2002. , 2002, Human immunology.

[17]  Kirby I Bland,et al.  Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer , 2002, The Lancet.

[18]  A. Hildesheim,et al.  Host and viral genetics and risk of cervical cancer: a review. , 2002, Virus research.

[19]  M. Berger,et al.  Epidemiology of primary brain tumors: current concepts and review of the literature. , 2002, Neuro-oncology.

[20]  Douglas C. Miller,et al.  Identification of Glutathione S-transferase (GST) Polymorphisms in Brain Tumors and Association with Susceptibility to Pediatric Astrocytomas , 2002, Journal of Neuro-Oncology.

[21]  J. Kere,et al.  A novel low-penetrance locus for familial glioma at 15q23-q26.3. , 2002, Cancer research.

[22]  C. Cobbs,et al.  Human cytomegalovirus infection and expression in human malignant glioma. , 2002, Cancer research.

[23]  H. Fine,et al.  History of allergies and autoimmune diseases and risk of brain tumors in adults , 2002, International journal of cancer.

[24]  R. Miike,et al.  History of allergies among adults with glioma and controls , 2002, International journal of cancer.

[25]  J. Isola,et al.  Cancer incidence in families with multiple glioma patients , 2002, International journal of cancer.

[26]  G. Voglino,et al.  Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes , 2001, International journal of cancer.

[27]  K. Cao,et al.  Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations. , 2001, Human immunology.

[28]  K. Aldape,et al.  Ethnicity delineates different genetic pathways in malignant glioma. , 2001, Cancer research.

[29]  N. Rainov,et al.  Brain Glioma and Human Leukocyte Antigens (HLA) – is There an Association , 2001, Journal of Neuro-Oncology.

[30]  S. H. van der Burg,et al.  Natural T‐helper immunity against human papillomavirus type 16 (hpv16) e7–derived peptide epitopes in patients with hpv16‐positive cervical lesions: Identification of 3 human leukocyte antigen class ii–restricted epitopes , 2001, International journal of cancer.

[31]  C. Amos,et al.  Segregation analysis of cancer in families of glioma patients , 2001, Genetic epidemiology.

[32]  H. Grönberg,et al.  Genetic epidemiology of glioma , 2001, British Journal of Cancer.

[33]  E. Karita,et al.  Characteristics of HLA Class I and Class II Polymorphisms in Rwandan Women , 2000, Experimental and Clinical Immunogenetics.

[34]  K. Aldape,et al.  Association of an ERCC1 polymorphism with adult-onset glioma. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[35]  J. Sidney,et al.  Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism , 1999, Immunogenetics.

[36]  D. Middleton,et al.  Genetic association studies of tumour necrosis factor α and β and tumour necrosis factor receptor 1 and 2 polymorphisms across the clinical spectrum of multiple sclerosis , 1999, Journal of Neurology.

[37]  G. Giles,et al.  Role of medical history in brain tumour development. Results from the international adult brain tumour study , 1999, International journal of cancer.

[38]  M. Berger,et al.  Centralized databases available for describing primary brain tumor incidence, survival, and treatment: Central Brain Tumor Registry of the United States; Surveillance, Epidemiology, and End Results; and National Cancer Data Base. , 1999, Neuro-oncology.

[39]  A. Silvani,et al.  Tumor necrosis factor microsatellite polymorphisms in Italian glioblastoma patients. , 1999, Cancer genetics and cytogenetics.

[40]  J. Sidney,et al.  HLA supertypes and supermotifs: a functional perspective on HLA polymorphism. , 1998, Current opinion in immunology.

[41]  J. Bruner,et al.  Genetic polymorphisms in glutathione S-transferase mu and theta, N-acetyltransferase, and CYP1A1 and risk of gliomas. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[42]  K. Kelsey,et al.  A population-based case-control study of the CYP2D6 and GSTT1 polymorphisms and malignant brain tumors. , 1997, Pharmacogenetics.

[43]  K. Kelsey,et al.  Population-based study of glutathione S-transferase mu gene deletion in adult glioma cases and controls. , 1997, Carcinogenesis.

[44]  R Miike,et al.  Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls. , 1997, American journal of epidemiology.

[45]  G. Swanson,et al.  Associations between human leukocyte antigen type and nasopharyngeal carcinoma in Caucasians in the United States. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[46]  F. Rousset,et al.  AN EXACT TEST FOR POPULATION DIFFERENTIATION , 1995, Evolution; international journal of organic evolution.

[47]  W. Klitz,et al.  HLA DR–DQ associations with cervical carcinoma show papillomavirus–type specificity , 1994, Nature Genetics.

[48]  J. Ragoussis,et al.  Map of the human MHC. , 1991, Immunology today.

[49]  M. Wrensch,et al.  Genetics of primary brain tumors: a review , 2005, Journal of Neuro-Oncology.

[50]  G. Giles,et al.  Occupational risk factors for low grade and high grade glioma: Results from an international case control study of adult brain tumours , 2005, International journal of cancer.

[51]  Kiyoshi Sato,et al.  Association of malignant glioma with the human leukocyte antigen, HLA-A24(9) , 2004, Neurosurgical review.

[52]  P. Black,et al.  Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the risk of adult brain tumors. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[53]  T. West,et al.  HLA associations with nasopharyngeal carcinoma in Southern Chinese: a meta-analysis. , 2002, Clinical otolaryngology and allied sciences.

[54]  J. Bruner,et al.  Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994. , 1999, Neuro-oncology.

[55]  J. Bruner,et al.  Genetic Polymorphisms in Glutathione S-Transferaset and 0, N-Acetyltransferase, and CYPJA1 and Risk of Gliomas' , 1998 .

[56]  M. Linet,et al.  Etiology of brain tumors in adults. , 1995, Epidemiologic reviews.

[57]  J. Ragoussis,et al.  Map of the human MHC. , 1991, Immunology today.